Back to search
FDAFDA · Food and drugs·Recall number D-0620-2018

Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454.

Published March 28, 2018 · Recall initiated: March 19, 2018

Summary

FDA records drug Class II recall D-0620-2018, published March 28, 2018 and initiated March 19, 2018. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 640,486 vaginal inserts; Lot: Lot #: a) 33812545A, 33812546A, 33812774A, Exp. 12/2018; 33812775A, Exp. 01/2019; 33812776A, 33812777A, Exp. 05/2019; 33813786A, 33813868A, Exp. 7/2019; 33813974A, 33814058A, Exp. 09/2019; 33814113A, Exp. 01/2019; b) 33812547A, 33813361A,33813676A, Exp. 1/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.

What to do

Voluntary: Firm initiated · Letter

Get an email if ESTRADIOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ESTRADIOL
Manufacturer
Teva Pharmaceuticals USA
Distributor
Distributed within the United States and Puerto Rico.
Lot
Lot #: a) 33812545A, 33812546A, 33812774A, Exp. 12/2018; 33812775A, Exp. 01/2019; 33812776A, 33812777A, Exp. 05/2019; 33813786A, 33813868A, Exp. 7/2019; 33813974A, 33814058A, Exp. 09/2019; 33814113A, Exp. 01/2019; b) 33812547A, 33813361A,33813676A, Exp. 1/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454. recalled?

Yes. FDA published recall D-0620-2018 on March 28, 2018. Reported hazard: Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ESTRADIOL.